Filing Details

Accession Number:
0001144204-11-038974
Form Type:
4
Zero Holdings:
No
Publication Time:
2011-07-05 11:25:16
Reporting Period:
2011-07-01
Filing Date:
2011-07-05
Accepted Time:
2011-07-05 11:25:16
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1095858 Ivax Diagnostics Inc IVD Pharmaceutical Preparations (2834) 113500746
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1500199 Kishore Dudani Transasia House
8 Chandivali Studio Road
Mumbai IN 400072
Yes No Yes No
1500200 Gmbh Mannheim Diagnostics Erba Mallaustr 69-73
Mannheim 2M 68219
Yes No Yes No
1500201 Ltd. Bio-Medicals Transasia Transasia House
8 Chandivali Studio Road
Mumbai IN 400072
No No Yes No
1500202 H. Suresh Vazirani Transasia House
8 Chandivali Studio Road
Mumbai IN 400072
Executive Chairman Of Board Yes Yes Yes No
1500277 S.r.o. Lachema Erba Karasek 1D
Brno 2N 62133
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, $0.01 Par Value Acquisiton 2011-07-01 20,000,000 $0.75 40,026,313 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock, $0.01 Par Value Common Stock Warrants (right to buy) Acquisiton 2011-07-01 20,000,000 $0.00 20,000,000 $0.75
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
20,000,000 2011-07-01 2016-07-01 No 4 P Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock, $0.01 Par Value 8,400 Indirect By subsidiary
Footnotes
  1. On July 1, 2011, the issuer sold and issued to ERBA Diagnostics Mannheim GmbH ("ERBA"), in a privately negotiated transaction pursuant to a stock purchase agreement, an aggregate of 20,000,000 shares of the issuer's common stock at a purchase price of $0.75 per share and warrants to purchase an additional 20,000,000 shares of the issuer's common stock.
  2. These shares were acquired under a stock purchase agreement pursuant to which (a) 6,666,667 shares were issued and delivered to ERBA upon ERBA's payment to the issuer of $5,000,000.25, (b) 6,666,667 shares will be issued and delivered to ERBA upon ERBA's payment to the issuer of $5,000,000.25 by no later than January 1, 2012 and (c) 6,666,666 shares will be issued and delivered to ERBA upon ERBA's payment to the issuer of $4,999,999.50 by no later than July 1, 2012.
  3. These shares are held directly by ERBA and indirectly by Transasia Bio-medicals Ltd., its corporate parent, and Suresh H. Vazirani, its controlling shareholder.
  4. These shares are held by Erba Lachema s.r.o., a direct wholly-owned subsidiary of ERBA.
  5. These warrants are held directly by ERBA and indirectly by Transasia Bio-medicals Ltd., its corporate parent, and Suresh H. Vazirani, its controlling shareholder.
  6. All of the reporting persons may be deemed to have beneficial ownership with respect to these securities, however, each reporting person disclaims such beneficial ownership except to the extent of his or its pecuniary interest therein.